QUEBRACHAMINE

CC[C@]12CCC[N@](C1)CCC3=C(CC2)NC4=CC=CC=C34

InChIKey=FDNDLNFGITWTOZ-LJQANCHMSA-N

InChI=1S/C19H26N2/c1-2-19-10-5-12-21(14-19)13-9-16-15-6-3-4-7-17(15)20-18(16)8-11-19/h3-4,6-7,20H,2,5,8-14H2,1H3/t19-/m1/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

PubMed

Title	Date	PubMed
Four decades of structure determination by mass spectrometry: from alkaloids to heparin.	2002 Nov	12443016
Enantioselective synthesis of 3,3-disubstituted piperidine derivatives by enolate dialkylation of phenylglycinol-derived oxazolopiperidone lactams.	2007 Jun 8	17488127
Organometallic chemistry: catalyst takes control to heart.	2008 Dec 18	19092919
Rhazinilam and quebrachamine derivatives from Yunnan Kopsia arborea.	2009 Feb 27	19133778
Design and stereoselective preparation of a new class of chiral olefin metathesis catalysts and application to enantioselective synthesis of quebrachamine: catalyst development inspired by natural product synthesis.	2009 Jan 28	19113867

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:49:42 GMT 2023` Edited by `admin` on `Sat Dec 16 09:49:42 GMT 2023`
Record UNII	7M37I29KEU
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

QUEBRACHAMINE

Common Name

English

QUEBRACHAMINE [MI]

Common Name

English

5.ALPHA.-QUEBRACHAMINE

Common Name

English

QUEBRACHAMINE, (+)-

Common Name

English

(+)-QUEBRACHAMINE

Common Name

English

2H-3,7-METHANOAZACYCLOUNDECINO(5,4-B)INDOLE, 7-ETHYL-1,4,5,6,7,8,9,10-OCTAHYDRO-, (7S)-

Systematic Name

English

Code System Code Type Description

FDA UNII

7M37I29KEU